Tagata, Letecia M.

HRN: 21-37-73  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2025
CO-AMOXICLAV 625MG (TAB)
06/09/2025
06/16/2025
PO
625mg
TID
Cap
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: